Abstract
Background
Accurate assessment of the internal mammary (IM) nodal basin can impact prognosis and treatment in breast cancer. The goal of this study was to identify characteristics associated with positive IM sentinel lymph nodes (SLNs) and the impact on adjuvant treatment.
Methods
Clinically node-negative breast cancer patients who underwent SLN dissection including removal of IM SLNs were identified and medical records were reviewed. Statistical analysis was performed using Fisher’s exact test and rank-sum tests with a significance level of 0.05.
Results
IM SLNs were removed in 71 patients, 60 (85 %) had negative IM SLNs, whereas 11 (15 %) had positive IM SLNs. Clinicopathologic characteristics were similar between the groups. The majority of patients in both groups had axillary SLNs removed (95 % in the node-negative group vs. 91 % in the node-positive group). Four patients (36 %) with positive IM SLNs had axillary metastasis; thus, IM nodal metastases were the only nodal metastases in 64 % of patients with positive IM SLNs. The identification of IM metastases altered adjuvant therapy in 5 (45 %) patients with positive IM SLNs.
Conclusions
Patients with positive IM SLNs have clinicopathologic features similar to those of patients with negative IM SLNs limiting the ability to predict IM nodal metastasis preoperatively. The identification of IM nodal metastases significantly impacts treatment decisions, especially when IM nodes are the only site of nodal metastasis. Removal of IM SLNs should be considered when lymphoscintigraphy reveals IM drainage.
Similar content being viewed by others
References
Edge S, Byrd D, Compton C, Fritz A, Greene F, Trotti A, eds. AJCC cancer staging manual, 7th ed. New York: Springer; 2010.
Veronesi U, Marubini E, Mariani L, Valagussa P, Zucali R. The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomised trial. Eur J Surg Oncol. 1999;35(9):1320–5.
Giuliano A, Dale P, Turner R, Morton D, Evans S, Krasne D. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg. 1995;222(3):394–9.
Coombs N, Boyages J, French J, Ung O. Internal mammary sentinel nodes: ignore, irradiate or operate? Eur J Cancer. 2009;45(5):789–94.
Johnson N, Soot L, Nelson J, et al. Sentinel node biopsy and internal mammary lymphatic mapping in breast cancer. Am J Surg. 2000;179(5):386–8.
Kong A, Tereffe W, Hunt K, et al. Impact of internal mammary lymph node drainage identified by preoperative lymphoscintigraphy on outcomes in patients with stage I to III breast cancer. Cancer. 2012;118:6287–96.
Tanis P, Nieweg O, Valdes Olmos R, Peterse J, Rutgers E, Hoefnagel C, Kroon B. Impact of non-axillary sentinel node biopsy on staging and treatment of breast cancer patients. Br J Cancer. 2002;87(7):705–10.
Kawase K, Gayed I, Hunt K, et al. Use of lymphoscintigraphy defines lymphatic drainage patterns before sentinel lymph node biopsy for breast cancer. J Am Coll Surg. 2006;203(1):64–72.
Farrus B, Vidal-Sicart S, Velasco M, et al. Incidence of internal mammary node metastases after a sentinel lymph node technique in breast cancer and its implication in the radiotherapy plan. Int J Radiat Oncol Biol Phys. 2004;60(3):715–21.
van der Ent F, Kengen R, van der Pol H, Povel J, Stroeken H, Hoofwijk A. Halsted revisited: internal mammary sentinel lymph node biopsy in breast cancer. Ann Surg. 2001;234(1):79–84.
Heuts E, van der Ent F, von Meyenfeldt M, Voogd A. Internal mammary lymph drainage and sentinel node biopsy in breast cancer: a study on 1,008 patients. Eur J Surg Oncol. 2009;35(3):252–7.
Estourgie S, Tanis P, Nieweg O, Valdes Olmos R, Rutgers E, Kroon B. Should the hunt for internal mammary chain sentinel nodes begin? An evaluation of 150 breast cancer patients. Ann Surg Oncol. 2003;10(8):935–41.
Madsen E, Gobardhan P, Bongers V, et al. The impact on post-surgical treatment of sentinel lymph node biopsy of internal mammary lymph nodes in patients with breast cancer. Ann Surg Oncol. 2007;14(4):1486–92.
Koo M, Lee S, Bae S, et al. Long-term outcome of internal mammary lymph node detected by lymphoscintigraphy in early breast cancer. J Breast Cancer. 2012;15(1):98–104.
van Rijk M, Tanis P, Nieweg O, Olmos R, Rutgers E, Hoefnagel C, Kroon B. Clinical implications of sentinel nodes outside the axilla and internal mammary chain in patients with breast cancer. J Surg Oncol, 2006;94(4):281–6.
Veronesi U, Arnone P, Veronesi P, et al. The value of radiotherapy on metastatic internal mammary nodes in breast cancer. Results on a large series. Ann Oncol. 2008;19(9):1553–60.
Carcoforo P, Sortini D, Feggi L, et al. Clinical and therapeutic importance of sentinel node biopsy of the internal mammary chain in patients with breast cancer: a single-center study with long-term follow-up. Ann Surg Oncol. 2006;13(10):1338–43.
Yu J, Li G, Wang Y. The pattern of lymphatic metastasis of breast cancer and its influence on the delineation of radiation fields. Int J Radiat Oncol Biol Phys. 2005;61(3):874–8.
Avisar E, Molina M, Scarlata M, Moffat F. Internal mammary sentinel node biopsy for breast cancer. Am J Surg. 2008;196(4):490–4.
Lacour J, Le M, Caceres E, Koszarowski T, Veronesi U, Hill C. Radical mastectomy versus radical mastectomy plus internal mammary dissection. Ten-year results of an international cooperative trial in breast cancer. Cancer. 1983;51(10):1941–3.
Veronesi U, Cascinelli N, Greco M, et al. Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann Surg. 1985;202(6):702–7.
Leidenius M, Krogerus L, Toivonen T, Leppanen E, von Smitten K. The clinical value of parasternal sentinel node biopsy in breast cancer. Ann Surg Oncol. 2006;13(3):321–6.
Yao M, Kurland B, Smith A, Schubert E, Dunnwald L, Byrd D, Mankoff D. Internal mammary nodal chain drainage is a prognostic indicator in axillary node-positive breast cancer. Ann Surg Oncol. 2007;14(10):2985–93.
Chagpar A, Kehdy F, Scoggins C, et al. Effect of lymphoscintigraphy drainage patterns on sentinel lymph node biopsy in patients with breast cancer. Am J Surg. 2005;190(4):557–62.
Mansel R, Goyal A, Newcombe R, Group AT. Internal mammary node drainage and its role in sentinel lymph node biopsy: the initial ALMANAC experience. Clin Breast Cancer. 2004;5(4):279–84.
Paredes P, Vidal-Sicart S, Zanon G, et al. Clinical relevance of sentinel lymph nodes in the internal mammary chain in breast cancer patients. Eur J Nucl Med Mol Imaging. 2005;32(11):1283–7.
Galimberti V, Veronesi P, Arnone P, et al. Stage migration after biopsy of internal mammary chain lymph nodes in breast cancer patients. Ann Surg Oncol. 2002;9(9):924–8.
Acknowledgement
The University of Texas MD Anderson Cancer Center is supported in part by the National Institutes of Health through Cancer Center Support Grant CA016672.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Caudle, A.S., Yi, M., Hoffman, K.E. et al. Impact of Identification of Internal Mammary Sentinel Lymph Node Metastasis in Breast Cancer Patients. Ann Surg Oncol 21, 60–65 (2014). https://doi.org/10.1245/s10434-013-3276-z
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-013-3276-z